Successful Treatment of Severe and Refractory Eosinophilic Pustular Folliculitis with Dupilumab: A Case Report with Two-Year Relapse-Free Follow-Up. [PDF]
J Inflamm ResJiang X, Wu X, Chen S, Cheng H.
europepmc +1 more source
Immunological Antagonism Between Psoriasis and Atopic Dermatitis: Pathways, Clinical Implications, and Therapeutic Perspectives. [PDF]
Clin Cosmet Investig DermatolQin J, Meng Z, Min W, Wang X, Zou Y.
europepmc +1 more source
Real-world efficacy and safety of dupilumab in the treatment of head and neck atopic dermatitis: a retrospective cohort study. [PDF]
Front Med (Lausanne)Li Z, Peng J, Yu R, Lin Y.
europepmc +1 more source
Dupilumab and House Dust Mite Immunotherapy in Patients with Atopic Dermatitis: A Preliminary Study [PDF]
Agnieszka Bogacz-Piaseczyńska +5 more
openalex +1 more source
Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study. [PDF]
World Allergy Organ JLi M, Lian C, Wang X.
europepmc +1 more source
Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab [PDF]
Liana Victory +6 more
openalex +1 more source
Combination of Omalizumab and Dupilumab for the Treatment of Severe Bullous Pemphigoid: a Series of 6 Cases. [PDF]
Acta Derm VenereolBoisseau R +4 more
europepmc +1 more source
Drug-Induced Bullous Pemphigoid Triggered by Immune Checkpoint Inhibitor Opdualag in an Elderly Patient With Recurrent Metastatic Melanoma: A Case Report and Treatment Course With Dupilumab. [PDF]
CureusMoreno BA, Lutwak M, Lutwak D, Kerdel F.
europepmc +1 more source
Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort study. [PDF]
JAAD IntAnand P +9 more
europepmc +1 more source